CGM Costs
From 1st July 2023, the Australian Government announced that the Guardian™ 4 Sensor will be subsidised for all Australians living with Type 1 diabetes.
Introducing a new AccessPlus program - Simplified loan program for MiniMed™ 780G. Discover More
Living with Diabetes? Check out our site for you
Healthcare professional? This is your dedicated site.
CGM Costs
From 1st July 2023, the Australian Government announced that the Guardian™ 4 Sensor will be subsidised for all Australians living with Type 1 diabetes.
Your patient may be eligible for Guardian™ 4 Sensor through the NDSS CGM subsidy scheme. Find out if your patient is eligible here.
If not, your patient can purchase a Subscription giving access to discounted pricing for our CGM technology. Please read the descriptions carefully to ensure your patient to purchase the correct subscription for the technology your patient is using.
Subscriptions
$50 PER SENSOR + GUARDIAN™ 4
12 boxes per year
$250 per month for 12 months
40% off RRP of $5,199
Save $2,199
ALWAYS FOLLOW THE DIRECTIONS FOR USE.
The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more. The MiniMed 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to provide an automatic adjustment of insulin delivery based on continuous glucose monitoring (CGM) and can suspend the delivery of insulin when the SG value falls below, or is predicted to fall below, predefined threshold values.
The Guardian 4 sensor is intended for use with the Guardian 4 transmitter to monitor glucose levels in persons with diabetes where self-monitoring of blood glucose (SMBG) is indicated. The sensor is designed to replace fingerstick blood glucose (BG)readings for diabetes treatment decisions. The sensor is intended for insertion into persons ages 7 years and older. The sensor is intended for insertion into the back of the upper arm or the upper buttocks in persons ages 7 through 17 years. The sensor is intended for insertion into the back of the upper arm or the abdomen in persons ages 18 years and older.